NEW YORK (360Dx) – SQI Diagnostics today announced a technology development partnership and licensing agreement with the McMaster University department of engineering to develop chip technology for multi-array disease testing. 

Initial work has begun and the partners are currently further developing the chip technology and detection devices to enable a wide array of multi-result tests that will be offered directly in clinical settings, SQI said. It did not elaborate on what illnesses the tests will target. Financial and other details were also not disclosed. 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.